newsfilter
← Latest News
GlobeNewswire·

Histogen Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update

SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ:HSTO), a clinical-stage therapeutics company focused on developing both restorative therapeutics and pan-caspase and caspase selective inhibitors focused on treatments for infectious a